- ►diabetesjournals.org M Fraenkel, M Ketzinel-Gilad, Y Ariav, O Pappo, M … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Unexpectedly, rapamycin worsened hyperglycemia in diabetic P. obesus without affecting
glycemia in normoglycemic controls. There was a 10-fold increase of serum insulin in diabetic P.
obesus compared with controls; ... Cited by 20 - Related articles - BL Direct - All 4 versions
- ►fasebj.org SS Lee, W Gao, S Mazzola, MN Thomas, E Csizmadia, … - The FASEB Journal, 2007 - FASEB Heme oxygenase-1 (HO-1) induction in, or carbon monoxide (CO), or bilirubin administration to,
donors and/or recipients frequently lead to long-term survival (>100 days) of DBA/2 islets into
B6AF1 recipients. We tested here ... Cited by 17 - Related articles - BL Direct - All 4 versions
PTT Pham, PCT Pham, GS Lipshutz, AH Wilkinson - … and Metabolism Clinics of …, 2007 - Elsevier New onset diabetes mellitus after transplantation (NODAT) is a well-known complication following
solid organ transplantation and has been reported to occur in 4% to 25% of renal transplant
recipients, 2.5% to 25% of liver ... Cited by 15 - Related articles - All 18 versions
P Fiorina, A Secchi - Endocrinology and Metabolism Clinics of North …, 2007 - Elsevier Islet cell transplantation recently has emerged as one the most promising therapeutic approaches to
improving glycometabolic control in type 1 diabetic patients, and, in many cases, to obtaining
insulin independence. Islet cell ... Cited by 13 - Related articles - All 17 versions
- ►diabetesresearch.org [PDF] T Froud, RN Faradji, A Pileggi, S Messinger, DA … - Transplantation, 2008 - journals.lww.com Tatiana Froud,1,2,3 Raquel N. Faradji,1,4 Antonello Pileggi,1,3 Shari Messinger,1,5 David A.
Baidal,1 Gaston M. Ponte,1 Pablo E. Cure,1 Kathy Monroy,1 Armando Mendez,1,4 Gennaro Selvaggi,1,3
Camillo Ricordi,1,3 and Rodolfo ... Cited by 12 - Related articles - All 5 versions
S Marzorati, A Pileggi, C Ricordi - Expert Opin. Biol. Ther., 2007 - informahealthcare.com Significant progress has been made in the field of β-cell replacement therapies by islet
transplantation in patients with unstable Type 1 diabetes mellitus (T1DM). Recent clinical trials
have shown that islet ... Cited by 11 - Related articles - BL Direct - All 6 versions
- ►daegu.ac.kr [PDF] S Marcelli-Tourvieille, T Hubert, E Moerman, V Gmyr, … - Transplantation, 2007 - journals.lww.com Skip Navigation Links Home > March 15, 2007 - Volume 83 - Issue 5 > In Vivo and In Vitro Effect of
Sirolimus on Insulin Secretio... ... 1 Department of Endocrinology and Metabolism and Endocrine
Surgery, INSERM Unit-M859, Diabetes ... Cited by 11 - Related articles - BL Direct - All 6 versions
S Subramanian, DL Trence - Endocrinology and Metabolism Clinics of North …, 2007 - Elsevier Since the first successful kidney transplant in 1959, transplantation medicine has evolved into
mainstream medical therapy. Such solid organ transplantation, however, would not have been possible
without the development of ... Cited by 6 - Related articles - All 20 versions
NF Brown, M Stefanovic-Racic, IJ Sipula, G Perdomo - Metabolism, 2007 - Elsevier The mammalian target of rapamycin (mTOR) is a conserved serine-threonine kinase that regulates cell
growth and metabolism in response to nutrient signals. However, the specific involvement of mTOR in
regulation of energy metabolism is ... Cited by 6 - Related articles - All 14 versions
